High-grade serous ovarian carcinoma with high expression of MYCN was sensitive to a BET inhibitor, suggesting that MCYN may be one of the drivers of the development of high-grade serous ovarian carcinoma.98 Here, MYCN is linked to ovarian serous carcinoma.